Study Title: Clinical Trial on Ultra-Thin Polyurethane Condoms
Published in Reprod Health, 2024 Sep 4;21(1):128
Objective: Evaluate breakage, slippage, and acceptability of two ultra-thin polyurethane condoms against a thin latex condom in a randomized, crossover, non-inferiority study.
Design: The study followed ISO 29943-1: 2017 and FDA guidelines, conducted at two Essential Access Health centers in California with 300 sexually active heterosexual couples aged 18-45.
Findings: Although polyurethane condoms had higher total failure rates than the latex control, they performed well. Polyurethane A met noninferiority requirements relative to Latex C, while Polyurethane B met the requirement in the intended population (men with penis lengths ≤ 170 mm).
Practical Solutions and Value: The study provides valuable insights into the performance of ultra-thin polyurethane condoms, offering potential benefits for sensitivity and STI prophylaxis. This information can guide clinicians and public health initiatives in promoting safer sex practices.
Clinical Impact: Clinical trials play a crucial role in improving medical practices. Our AI-driven platform, DocSym, consolidates clinical standards and research, facilitating informed decision-making for healthcare professionals. Additionally, our mobile apps support streamlined operations, including scheduling, treatment monitoring, and telemedicine, ultimately enhancing patient care and digital service expansion.
Technology Integration: AI tools can optimize clinic workflows and enhance patient outcomes while reducing paper-based routines. Explore how our solutions at aidevmd.com can benefit healthcare providers and patients alike.
